139 related articles for article (PubMed ID: 31405635)
1. Household costs of seeking BCG vaccination in rural Guinea-Bissau.
Thysen SM; Byberg S; Martins JSD; Kallestrup P; Griffiths UK; Fisker AB
Vaccine; 2019 Sep; 37(37):5505-5508. PubMed ID: 31405635
[TBL] [Abstract][Full Text] [Related]
2. Household experience and costs of seeking measles vaccination in rural Guinea-Bissau.
Byberg S; Fisker AB; Rodrigues A; Balde I; Enemark U; Aaby P; Benn CS; Griffiths UK
Trop Med Int Health; 2017 Jan; 22(1):12-20. PubMed ID: 27717100
[TBL] [Abstract][Full Text] [Related]
3. The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial.
Schaltz-Buchholzer F; Frankel HN; Benn CS
Glob Health Action; 2017; 10(1):1-4. PubMed ID: 28169606
[TBL] [Abstract][Full Text] [Related]
4. Can earlier BCG vaccination reduce early infant mortality? Study protocol for a cluster randomised trial in Guinea-Bissau.
Thysen SM; Jensen AKG; Rodrigues A; Borges IDS; Aaby P; Benn C; Fisker A
BMJ Open; 2019 Sep; 9(9):e025724. PubMed ID: 31551370
[TBL] [Abstract][Full Text] [Related]
5. BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study.
Thysen SM; Byberg S; Pedersen M; Rodrigues A; Ravn H; Martins C; Benn CS; Aaby P; Fisker AB
BMC Public Health; 2014 Oct; 14():1037. PubMed ID: 25282475
[TBL] [Abstract][Full Text] [Related]
6. Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study.
Funch KM; Thysen SM; Rodrigues A; Martins CL; Aaby P; Benn CS; Fisker AB
Hum Vaccin Immunother; 2018; 14(10):2434-2442. PubMed ID: 29293396
[TBL] [Abstract][Full Text] [Related]
7. Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0-4 years.
Thysen SM; Fisker AB; Byberg S; Aaby P; Roy P; White R; Griffiths U; Harris RC
BMJ Glob Health; 2021 Aug; 6(8):. PubMed ID: 34344667
[TBL] [Abstract][Full Text] [Related]
8. Development of BCG Scar and Subsequent Morbidity and Mortality in Rural Guinea-Bissau.
Storgaard L; Rodrigues A; Martins C; Nielsen BU; Ravn H; Benn CS; Aaby P; Fisker AB
Clin Infect Dis; 2015 Sep; 61(6):950-9. PubMed ID: 26060293
[TBL] [Abstract][Full Text] [Related]
9. Cohort profile : Bandim Health Project's (BHP) rural Health and Demographic Surveillance System (HDSS)-a nationally representative HDSS in Guinea-Bissau.
Thysen SM; Fernandes M; Benn CS; Aaby P; Fisker AB
BMJ Open; 2019 Jun; 9(6):e028775. PubMed ID: 31189684
[TBL] [Abstract][Full Text] [Related]
10. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau.
Roth A; Jensen H; Garly ML; Djana Q; Martins CL; Sodemann M; Rodrigues A; Aaby P
Pediatr Infect Dis J; 2004 Jun; 23(6):544-50. PubMed ID: 15194836
[TBL] [Abstract][Full Text] [Related]
11. Different effects of BCG strains - A natural experiment evaluating the impact of the Danish and the Russian BCG strains on morbidity and scar formation in Guinea-Bissau.
Frankel H; Byberg S; Bjerregaard-Andersen M; Martins CL; Aaby P; Benn CS; Fisker AB
Vaccine; 2016 Aug; 34(38):4586-4593. PubMed ID: 27491688
[TBL] [Abstract][Full Text] [Related]
12. Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial.
Jensen KJ; Larsen N; Biering-Sørensen S; Andersen A; Eriksen HB; Monteiro I; Hougaard D; Aaby P; Netea MG; Flanagan KL; Benn CS
J Infect Dis; 2015 Mar; 211(6):956-67. PubMed ID: 25210141
[TBL] [Abstract][Full Text] [Related]
13. Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study.
Thysen SM; Benn CS; Gomes VF; Rudolf F; Wejse C; Roth A; Kallestrup P; Aaby P; Fisker A
BMJ Open; 2020 Feb; 10(2):e035595. PubMed ID: 32114478
[TBL] [Abstract][Full Text] [Related]
14. Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002.
Roth A; Sodemann M; Jensen H; Poulsen A; Gustafson P; Gomes J; Djana Q; Jakobsen M; Garly ML; Rodrigues A; Aaby P
Vaccine; 2005 Jun; 23(30):3991-8. PubMed ID: 15899539
[TBL] [Abstract][Full Text] [Related]
15. Can BCG vaccination at first health-facility contact reduce early infant mortality? Study protocol for a cluster-randomised trial (CS-BCG).
Thysen SM; Møller Jensen A; Vedel JO; da Silva Borges I; Aaby P; Jensen AKG; Benn CS; Fisker AB
BMJ Open; 2022 Nov; 12(11):e063872. PubMed ID: 36410811
[TBL] [Abstract][Full Text] [Related]
16. Six years' experience with the discontinuation of BCG vaccination. 2. Cost and benefit of mass BCG vaccination.
Trnka L; Danková D; Svandová E
Tuber Lung Dis; 1993 Aug; 74(4):288-92. PubMed ID: 8219182
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?
Aaby P; Roth A; Ravn H; Napirna BM; Rodrigues A; Lisse IM; Stensballe L; Diness BR; Lausch KR; Lund N; Biering-Sørensen S; Whittle H; Benn CS
J Infect Dis; 2011 Jul; 204(2):245-52. PubMed ID: 21673035
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.
Byberg S; Fisker AB; Thysen SM; Rodrigues A; Enemark U; Aaby P; Benn CS; Griffiths UK
Glob Health Action; 2017; 10(1):1329968. PubMed ID: 28580855
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
[TBL] [Abstract][Full Text] [Related]
20. A review of the literature on the economics of vaccination against TB.
Tu HA; Vu HD; Rozenbaum MH; Woerdenbag HJ; Postma MJ
Expert Rev Vaccines; 2012 Mar; 11(3):303-17. PubMed ID: 22380823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
